Cyclodextrins unlock the full potential of lipopeptides — reducing cytotoxicity while keeping their antimicrobial efficacy intact
Over the past decade, the growing threat of antibiotic resistance has intensified interest in antimicrobial peptides and lipopeptides as promising
